Updated Jul 16, 2026
Clemmer James C is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $232K.
James C. Clemmer is the President and CEO of AngioDynamics Inc, a company specializing in medical devices for treating peripheral vascular disease and oncology. He has been involved in the medical technology industry and has held leadership roles within the company.
| Role | Insider |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-10-09 | ANGO | ANGIODYNAMICS INC | P — Open-market purchase | 10.0K | $11.15 | $112K |
| 2025-07-19 | ANGO | ANGIODYNAMICS INC | F — Tax withholding / forfeiture | 3.7K | $8.99 | $33K |
| 2025-07-19 | ANGO | ANGIODYNAMICS INC | F — Tax withholding / forfeiture | 3.0K | $8.69 | $26K |
| 2025-07-19 | ANGO | ANGIODYNAMICS INC | F — Tax withholding / forfeiture | 8.3K | $8.69 | $72K |
| 2025-07-19 | ANGO | ANGIODYNAMICS INC | F — Tax withholding / forfeiture | 344 | $8.69 | $3K |
| 2025-07-16 | ANGO | ANGIODYNAMICS INC | A — Grant or award | 206.3K | $0.00 | |
| 2024-10-08 | ANGO | ANGIODYNAMICS INC | P — Open-market purchase | 20.0K | $6.03 | $121K |
James C. Clemmer is the President and CEO of AngioDynamics Inc, a company specializing in medical devices for treating peripheral vascular disease and oncology. He has been involved in the medical technology industry and has held leadership roles within the company.…
Recorded transactions: 2 open-market purchases ($232K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Clemmer James C profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.